Head and neck cancers, Laryngeal cancer, Mouth and oropharyngeal cancer
Results
Phase 3
This trial compared nivolumab with standard treatment. It was for people with advanced recurrent or metastatic head and neck cancer. That is head and neck cancer that has come back or spread to another part of the body.The people taking part had a type of head and neck cancer called of the:
Recruitment start: 10 June 2014
Recruitment end: 23 June 2015
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Kevin Harrington
Bristol-Myers Squibb
NIHR Clinical Research Network: Cancer
Last reviewed: 14 February 2018
CRUK internal database number: 12216
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
